Showing results (281-290 of 734) with videos related to

Sort By:
Pageof 74
Leukemia|July 1, 2020
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignanciesPhilippe Armand, Alexander Lesokhin, Ivan Borrello, et al.
Annals of the Rheumatic Diseases|October 1, 1978
A comparative study of Butacote and Naprosyn in ankylosing spondylitisB M Ansell, G Major, S P Liyanage, et al.
Leukemia & Lymphoma|July 16, 2005
Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphomaIrene M Ghobrial, Roger H Weenig, Mark R Pittlekow, et al.
American Journal of Hematology|December 4, 2008
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphomaStephen M Ansell, Anne J Novak, Steven Ziesmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 12, 2022
Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphomaMadiha Iqbal, Liuyan Jiang, Ke David Li, et al.
Blood Cancer Journal|March 14, 2018
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignanciesPraful Ravi, Shaji K Kumar, James R Cerhan, et al.
Neurology|February 13, 2018
Primary central nervous system vasculitis associated with lymphomaCarlo Salvarani, Robert D Brown, Teresa J H Christianson, et al.
Clinical and Experimental Rheumatology|November 1, 1989
Low-dose methotrexate in systemic onset juvenile chronic arthritisM Speckmaier, J Findeisen, P Woo, et al.
Clinical and Experimental Rheumatology|September 1, 1989
Serum IGF-I levels and growth failure in juvenile chronic arthritisT J Aitman, R G Palmer, J Loftus, et al.
Leukemia & Lymphoma|December 29, 2004
Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab eraIrene M Ghobrial, Thomas M Habermann, Kay M Ristow, et al.
Pageof 74